Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD

NCT00530842 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium plus Salmeterol
DRUG: Fluticasone/Salmeterol

Sponsor

Boehringer Ingelheim